Background: 25-Hydroxyvitamin D (25(OH)D) deficiency is the most common complication of kidney disease. Previous studies have suggested that 25(OH)D deficiency is involved in the pathogenesis of anemia in kidney disease subjects not requiring dialysis. However, these associations have not been investigated in peritoneal dialysis (PD) patients.
Results

Clinical characteristics and biochemical parameters
Basal clinical characteristics of the studied groups are presented in Table 1 . The mean age was 51 ± 12.9 years, and there were 44 males and 36 females. The mean serum 25(OH)D3 concentration was 12.29 ± 13.37 ng/mL, while the mean 25(OH)D3 level was 21.37 ± 15.99 ng/mL in group 1 and 5.025 ± 2.814 ng/mL in group 2. As seen in Table 1 , there were statistical significance in the level of BUN, albumin, hemoglobin, iPTH, hepcidin, and hs-CRP between group 1 and group 2. However, there were no significant differences in age, sex, BMI, duration of dialysis, serum iron, TIBC, ferritin, creatinine, phosphate, calcium, and total kt/v between the two groups. 
Association between biochemical parameters and anemia
According to the criteria for anemia (The National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (NKF-KDOQI) guidelines recommended that hemoglobin targets should be in the range of (100-115 g/L) [15] . In this study, 42.5% of participants were anemic. As seen in 
Association between serum 25(OH)D level and anemia
Pearson's correlation analysis ( 
Association between serum 25(OH)D level and biochemical parameters
As seen in 
Discussion
In this cross-sectional study, our results showed that 25(OH)D insufficiency was prevalent in PD patients and the proportion of 25(OH)D insufficiency(25(OH)D concentration above 30 ng/mL in 5cases) was 93.75%, which is consistent with a previous study [16] . The possible causes of 25(OH)D deficiency include chronic pathogenesis of renal failure, lack of intake, vitamin D loss from the peritoneal effluent [16] . The prevalence of vitamin D insufficiency may also correlate with the northern location of our study area, as well as and inadequate amount of sun exposure [17, 18] and dietary habits.
It is generally accepted that anemia is a common complication in PD patients, and its pathogenesis is multifactorial. The primary causes of anemia in PD patients, just as in CKD, include low erythropoietin levels, iron and protein deficiency, and decreased half-life of circulating red blood cells. Moreover, malnutrition, inflammation, and atherosclerosis are additional causes of anemia. As described by previous reports, our results also indicated that albumin, hs-CRP, phosphorus, iPTH, BUN, hepcidin, and dialysis adequacy influenced hemoglobin concentration in PD patients. Interesting, accumulating evidence shows that 25(OH)D deficiency is associated with a reduction in circulating levels of hemoglobin concentrations in the non-uremic population [11] , and a few studies have shown that treatment with vitamin D compounds appeared to improve anemia in hemodialysis patients [7, 8] . In the present cross-sectional study, our results also showed a stepwise increase in hemoglobin concentration with increasing 25(OH)D levels (p<0.01). Previously, a few reports demonstrated that 25(OH)D suppresses pro-inflammatory cytokines and increases anti-inflammatory cytokines [10] , and treatment with vitamin D3 significantly decreased levels of the pro-inflammatory cytokine TNF-α and significantly increased levels of the anti-inflammatory cytokine interleukin-10 in a study of healthy non-CKD patients [19] . However, we did not detect the level of TNF-α and anti-inflammatory cytokines. Fortunately, a previous study showed that CRP is the most generally used acute-phase protein and represents the degree of inflammation [20] . In this study, Pearson's correlation analysis and multivariate linear regression analysis a revealed that Hb concentration was also negatively correlated with hs-CRP and Pearson's correlation analysis showed that serum 25(OH)D level significantly correlated with hs-CRP (r=-0.2673, p=0.0165). When these former studies are considered in the context of the present findings, it is intriguing to speculate that 25(OH)D level may affect hemoglobin levels, at least in part, through its regulation of inflammatory marker. This speculation is also supported by a report that in PD patients, vitamin D supplementation in vitro and in vivo promotes innate immune responses that may enhance macrophage antibacterial responses and prevent infection-related complications [21] , and 25(OH)D deficiency increased levels of inflammatory factor and results in a decreased response to erythropoietin [22] .
More recently, a report has shown that 25(OH)D can suppress the expression of an antibacterial protein (hepcidin) [23] in dialysis patients. Hepcidin, a recently discovered small, cysteine-rich cationic peptide hormone produced in the liver, is the key regulator of iron homeostasis [24] , and is regulated in response to anemia, hypoxia, and inflammation [25] . Just as in hemodialysis patients [26] , our results show that serum hepcidin was markedly increased in PD patients and was inversely associated with hemoglobin level. A possible mechanism is that increased hepcidin was involved in elimination of hepcidin from the kidney [27] and endogenous erythropoietin deficiency [25] . We also found that increased hepcidin levels were inversely related with 25(OH)D levels, supporting a previous report that disorders of mineral metabolism may promote increased hepcidin secretion in CKD not yet requiring dialysis [28] . humans [23] , which suppressed intracellular iron transport and then cause the anemia developing [29] . However, in our study there was no significant correlation between hepcidin, and serum iron and ferritin, which was inconsistent with a previously published paper [30] , which was perhaps due to a small sample. Take these results together, we speculated that 25(OH)D insufficiency may promote hepcidin secretion, which impede utilization of iron, and result in the development of anemia in PD patients. If so, supplementary vitamin D could be a novel method for decreasing hepcidin levels and thereby improving anemia in PD patients.
Nevertheless, a few limitations in the current study should be noted. First, the cross-sectional design makes it difficult to establish a causal relationship between vitamin D deficiency and anemia. Second, this was a single-center study and the sample in our study was not large enough, so additional studies with larger numbers of participants are needed to further establish the potential relationships between vitamin D deficiency and anemia. In addition, all participants in this study residents of northeastern China, which may affect generalizability of the results to other regions because the prevalence of 25(OH)D deficiency varies with latitude [18] .
In summary, 25(OH)D insufficient and anemia are a common problem in PD patients. Our study has shown that lower 25(OH)D levels affect the hemoglobin level, which may be involved in hepcidin and inflammation in PD patients. Future studies should be designed for cohort study and increase the number of samples, and regional issues should be considered.
